drugset / Trial / NCT00651846
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
RandomizedCrossoverQuadruple-blindTreatment
Summary
The objective of this study was to investigate the impact of the oral contraceptive YASMIN (containing: drospirenone 3 mg/ethinyl estradiol 30 mcg) in comparison with the oral contraceptive MICROGYNON (containing: levonorgestrel 150 mcg/ethinyl estradiol 30mcg) on factors of blood coagulation and fibrinolysis in female subjects
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levonorgestrel | Small molecule | 0.15 mg | Oral |
| Subject | drospirenone | Unknown | 3 mg | Oral |
| Background | ethinyl estradiol | Small molecule | 0.03 mg | Oral |
Indications
No indication recorded.